Biomega, officially known as Biomega Group, is a leading player in the biotechnology industry, headquartered in Norway. Founded in 2001, the company has established itself as a pioneer in the development of sustainable marine ingredients, primarily focusing on omega-3 fatty acids derived from fish and algae. With a strong operational presence in Europe and North America, Biomega is committed to enhancing health and nutrition through its innovative products. The company’s core offerings include high-quality omega-3 oils, which are distinguished by their purity and sustainability. Biomega's commitment to environmentally responsible sourcing and production has positioned it as a trusted name in the market. Notable achievements include certifications for quality and sustainability, reinforcing its reputation as a leader in the health and wellness sector.
How does Biomega's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biomega's score of 37 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Biomega reported total carbon emissions of approximately 6,716,200 kg CO2e globally, with significant contributions from Scope 1 and Scope 3 emissions. Specifically, Scope 1 emissions accounted for about 6,288,900 kg CO2e, while Scope 2 emissions were approximately 427,300 kg CO2e. Notably, Scope 3 emissions reached around 8,660,900 kg CO2e, with the largest share coming from purchased goods and services at about 6,764,200 kg CO2e. In Norway, Biomega's emissions for 2023 included approximately 5,438,600 kg CO2e from Scope 1 and 120,400 kg CO2e from Scope 2. In Denmark, the company reported Scope 1 emissions of about 850,300 kg CO2e and Scope 2 emissions of approximately 307,000 kg CO2e. Biomega has established near-term greenhouse gas reduction targets for its Hirtshals facility, focusing on both Scope 1 and Scope 2 emissions. These baselines were set in 2023, with an acknowledgment that they may evolve as production stabilises. The targets are set to be reviewed by 2025. Biomega's commitment to reducing its carbon footprint aligns with industry standards, and while specific SBTi targets have not been disclosed, the company is actively working towards achieving net-zero emissions in the near term.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 6,097,600  | 0,000,000  | 
| Scope 2 | 377,100  | 000,000  | 
| Scope 3 | -  | 0,000,000  | 
Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 56% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biomega has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
